Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, recording a newer internal version of the page.
    Difference
    0.0%
    Check dated 2026-07-26T13:48:57.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.2 to v3.6.3. This signals a minor page/template update rather than any changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-05T04:30:34.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, representing an internal update to the ClinicalTrials.gov page. Substantive study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T23:45:24.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants, indicating the study is not enrolling. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was adjusted for consistency.
    Difference
    0.3%
    Check dated 2026-06-13T17:16:39.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4. This reflects a small update to the page's revision history rather than any substantive change to study details or navigation.
    Difference
    0.0%
    Check dated 2026-06-06T13:23:40.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page’s revision metadata was updated from v3.5.3 to v3.5.4, indicating an internal platform update. There is no indication that the study content or user-facing information was altered.
    Difference
    0.0%
    Check dated 2026-05-16T07:36:43.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.